TCF7L1 and neoplasm: Mice that were administered subcutaneous injections of PC3 cells harboring TCF7L1-KD showed no changes in tumor growth rates or tumor weights compared to mice injected with cells carrying the NC shRNA (Supplementary Fig. S3D–F).